Skip to content

Reducing Binge Eating to Prevent Weight Gain in Black Women

Reducing Binge Eating to Prevent Weight Gain in Black Women: A Pilot Study

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03531112
Enrollment
20
Registered
2018-05-21
Start date
2019-01-12
Completion date
2020-02-13
Last updated
2021-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Binge Eating, Weight Gain Prevention, Weight Loss

Brief summary

The purpose of the proposed study is to pilot a 6-month, cognitive-behavioral binge eating intervention, Appetite Awareness Training (AAT) to reduce binge eating and prevent weight gain for Black women with a BMI \> 25 kg/m\^2 and with weekly binge eating episodes. Intervention participants will receive a 8-week group AAT intervention, and will also receive bluetooth-connected scales for daily weighing. Participants will also receive tailored feedback on self-weighing frequency and weight change. The investigators will follow-up with participants at six months.

Detailed description

Aim 1. Using an experimental design, examine the feasibility and acceptability of 6-month AAT (N=40) in North Carolina. Forty overweight and obese (BMI ≥ 25 kg/m\^2) community-based Black women will be randomized to the AAT intervention or wait-list control (who will eventually receive the intervention). AAT participants will meet weekly for 8 weeks, followed by a 4-month period of daily weighing and weekly tailored feedback only. The study will examine the following: recruitment feasibility, attendance/retention, adherence, satisfaction, and barriers to completion. Aim 2: At 4 and 6 months, compare changes in (a) binge eating, eating self-efficacy, and depressive symptoms and (b) weight, blood pressure, and waist circumference for participants in the intervention vs. control group. H\_1: Participants in the AAT intervention will report less binge and overeating and gain less weight than those in the control group at 2 and 6 months. Secondary aim: Examine characteristics (e.g., baseline BMI, severity of binge eating, frequency of self-weighing) related to change in binge eating and weight.

Interventions

BEHAVIORALAppetite Awareness Treatment + Lifestyle Modification

The AAT + LM intervention includes 16 60-90 minute group sessions to enable participants to be able to relearn their stomach's hunger signals and begin to obey and monitor functions of satiety. All sessions involve didactic training, review of self-monitoring of eating episodes, interactive activities, and homework assignments to enable participants to practice learned skills. Participants will be provided a workbook, which will include session content, and self-monitoring forms.

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
University of North Carolina, Chapel Hill
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

The proposed study will use a randomized clinical trial design. A sample of 40 black women who report at least weekly binge eating episodes will be randomized to 2 arms of a 6-month AAT intervention: AAT or a wait-list control group (delayed intervention group). AAT participants will receive an 8-week AAT program using a group format, and will be provided a smart scale (with bluetooth-connection for automatic data reporting) and instructions to weigh themselves daily. Participants will also be provided with weekly tailored feedback on self-weighing frequency and weight change. Assessments will be conducted at 0, 2, and 6 months.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

Individuals are eligible if they are: * non-Latino Black women, * over 18 years of age, * have a BMI ≥ 25kg/m\^2, * use a Bluetooth-enabled smartphone, * report at least one binge eating episode weekly, and * complete the screening.

Exclusion criteria

Individuals will be excluded if they: * are currently pregnant, * are in substance abuse treatment, * are involved in another weight reduction program, * have a history of anorexia, * are purging, * are currently in treatment for eating difficulties, * are concurrent intravenous drug users or consume \>4 alcoholic beverages/day.

Design outcomes

Primary

MeasureTime frameDescription
Feasibility (Recruitment): Total Number of Participants Who Were Eligible and Enrolled in the StudyMonth 6Recruitment is defined as the number of potential participants screened for study eligibility versus the number of persons who enrolled in the study.
Feasibility (Retention): Percentage of Participants Retained in the StudyMonth 6Percentage of participants retained in the study following enrollment through month 6
Feasibility (Attendance): Percentage of Sessions That Were AttendedMonth 2Each session attended by participants was captured. The number of sessions attended for each participant were summed and then divided by the number of total participants and multiplied by 100.

Secondary

MeasureTime frameDescription
Mean Change in Binge Eating Scale Score From Baseline to Month 6Baseline, Month 6This measure contains 16 questions that describe both behavioral and emotional manifestations of a binge episode. This scale was specifically developed to assess binge eating severity and associated emotional distress in overweight and obese individuals. The total score for the measure ranges from 0-46 points with higher scores indicating greater problems with binge eating and lower scores indicating better outcome.
Median Weight Change From Baseline to Month 4Baseline, Month 4Measured in Kg
Mean Objective Binge Eating Episodesup to 6 monthsParticipants were administered the interviewer-based overeating section of the Eating Disorder Examination (EDE) to assess objective binge eating episodes (OBE) (i.e., consumption of an objectively large amount of food and loss of control over eating) within the 28 days prior. Assessed at Baseline, Month 4, and Month 6.
Median Weight Change From Baseline to Month 6Baseline, Month 6Measured in Kg
Mean Change in Binge Eating Scale Score From Baseline to Month 2Baseline, Month 2This measure contains 16 questions that describe both behavioral and emotional manifestations of a binge episode. This scale was specifically developed to assess binge eating severity and associated emotional distress in individuals with overweight and obesity. The total score for the measure ranges from 0-46 points with higher scores indicating greater problems with binge eating and lower scores indicating better outcome.

Countries

United States

Participant flow

Pre-assignment details

Study terminated prior to enrollment of control participants.

Participants by arm

ArmCount
Appetite Awareness Treatment + Lifestyle Modification
Appetite Awareness Treatment + Lifestyle Modification: The AAT + LM intervention includes 16 60-90 minute group sessions to enable participants to be able to relearn their stomach's hunger signals and begin to obey and monitor functions of satiety. All sessions involve didactic training, review of self-monitoring of eating episodes, interactive activities, and homework assignments to enable participants to practice learned skills. Participants will be provided a workbook, which will include session content, and self-monitoring forms.
20
Control
Control group participants will receive no intervention in months 1-6, but will be offered the chance to receive an abbreviated form of AAT (4 weeks) following the 6-month assessment.
0
Total20

Baseline characteristics

CharacteristicAppetite Awareness Treatment + Lifestyle ModificationTotal
Age, Continuous46.4 years
STANDARD_DEVIATION 13.8
46.4 years
STANDARD_DEVIATION 13.8
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
20 Participants20 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants
Race (NIH/OMB)
Black or African American
20 Participants20 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants
Race (NIH/OMB)
White
0 Participants0 Participants
Region of Enrollment
United States
20 Participants20 Participants
Sex: Female, Male
Female
20 Participants20 Participants
Sex: Female, Male
Male
0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 200 / 0
other
Total, other adverse events
0 / 200 / 0
serious
Total, serious adverse events
0 / 200 / 0

Outcome results

Primary

Feasibility (Attendance): Percentage of Sessions That Were Attended

Each session attended by participants was captured. The number of sessions attended for each participant were summed and then divided by the number of total participants and multiplied by 100.

Time frame: Month 2

Population: Study terminated prior to enrollment of control participants. Data not included for three participants who discontinued.

ArmMeasureValue (NUMBER)
Appetite Awareness Treatment + Lifestyle ModificationFeasibility (Attendance): Percentage of Sessions That Were Attended56 percentage of sessions per participant
Primary

Feasibility (Recruitment): Total Number of Participants Who Were Eligible and Enrolled in the Study

Recruitment is defined as the number of potential participants screened for study eligibility versus the number of persons who enrolled in the study.

Time frame: Month 6

Population: Study terminated prior to enrollment of control participants. The number of potential participants screened for study eligibility

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Appetite Awareness Treatment + Lifestyle ModificationFeasibility (Recruitment): Total Number of Participants Who Were Eligible and Enrolled in the Study20 Participants
Primary

Feasibility (Retention): Percentage of Participants Retained in the Study

Percentage of participants retained in the study following enrollment through month 6

Time frame: Month 6

Population: Study terminated prior to enrollment of control participants.

ArmMeasureValue (NUMBER)
Appetite Awareness Treatment + Lifestyle ModificationFeasibility (Retention): Percentage of Participants Retained in the Study85 percentage of participants
Secondary

Mean Change in Binge Eating Scale Score From Baseline to Month 2

This measure contains 16 questions that describe both behavioral and emotional manifestations of a binge episode. This scale was specifically developed to assess binge eating severity and associated emotional distress in individuals with overweight and obesity. The total score for the measure ranges from 0-46 points with higher scores indicating greater problems with binge eating and lower scores indicating better outcome.

Time frame: Baseline, Month 2

Population: Data were not collected using the Binge Eating Scale and were instead collected using the Eating Disorder Examination

Secondary

Mean Change in Binge Eating Scale Score From Baseline to Month 6

This measure contains 16 questions that describe both behavioral and emotional manifestations of a binge episode. This scale was specifically developed to assess binge eating severity and associated emotional distress in overweight and obese individuals. The total score for the measure ranges from 0-46 points with higher scores indicating greater problems with binge eating and lower scores indicating better outcome.

Time frame: Baseline, Month 6

Population: Data were not collected using the Binge Eating Scale and were instead collected using the Eating Disorder Examination

Secondary

Mean Objective Binge Eating Episodes

Participants were administered the interviewer-based overeating section of the Eating Disorder Examination (EDE) to assess objective binge eating episodes (OBE) (i.e., consumption of an objectively large amount of food and loss of control over eating) within the 28 days prior. Assessed at Baseline, Month 4, and Month 6.

Time frame: up to 6 months

Population: Study terminated prior to enrollment of control participants.

ArmMeasureGroupValue (MEAN)Dispersion
Appetite Awareness Treatment + Lifestyle ModificationMean Objective Binge Eating EpisodesMonth 42.1 binge eating episodesStandard Deviation 5.1
Appetite Awareness Treatment + Lifestyle ModificationMean Objective Binge Eating EpisodesMonth 62.6 binge eating episodesStandard Deviation 6.9
Appetite Awareness Treatment + Lifestyle ModificationMean Objective Binge Eating EpisodesBaseline6.5 binge eating episodesStandard Deviation 7.8
Secondary

Median Weight Change From Baseline to Month 4

Measured in Kg

Time frame: Baseline, Month 4

Population: Study terminated prior to enrollment of control participants. Data not included for three participants who discontinued.

ArmMeasureValue (MEDIAN)
Appetite Awareness Treatment + Lifestyle ModificationMedian Weight Change From Baseline to Month 40 Kg
Secondary

Median Weight Change From Baseline to Month 6

Measured in Kg

Time frame: Baseline, Month 6

Population: Study terminated prior to enrollment of control participants. Data not included for seven participants who discontinued.

ArmMeasureValue (MEDIAN)
Appetite Awareness Treatment + Lifestyle ModificationMedian Weight Change From Baseline to Month 6-0.2 Kg

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026